235 related articles for article (PubMed ID: 12654779)
1. Surfactant protein D-mediated aggregation of Pneumocystis carinii impairs phagocytosis by alveolar macrophages.
Yong SJ; Vuk-Pavlovic Z; Standing JE; Crouch EC; Limper AH
Infect Immun; 2003 Apr; 71(4):1662-71. PubMed ID: 12654779
[TBL] [Abstract][Full Text] [Related]
2. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages.
O'Riordan DM; Standing JE; Kwon KY; Chang D; Crouch EC; Limper AH
J Clin Invest; 1995 Jun; 95(6):2699-710. PubMed ID: 7769109
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis carinii enhances soluble mannose receptor production by macrophages.
Fraser IP; Takahashi K; Koziel H; Fardin B; Harmsen A; Ezekowitz RA
Microbes Infect; 2000 Sep; 2(11):1305-10. PubMed ID: 11018446
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrate recognition domain of surfactant protein D mediates interactions with Pneumocystis carinii glycoprotein A.
Vuk-Pavlovic Z; Standing JE; Crouch EC; Limper AH
Am J Respir Cell Mol Biol; 2001 Apr; 24(4):475-84. PubMed ID: 11306442
[TBL] [Abstract][Full Text] [Related]
5. Effect of bronchoalveolar lavage fluid from Pneumocystis carinii-infected hosts on phagocytic activity of alveolar macrophages.
Lasbury ME; Lin P; Tschang D; Durant PJ; Lee CH
Infect Immun; 2004 Apr; 72(4):2140-7. PubMed ID: 15039336
[TBL] [Abstract][Full Text] [Related]
6. Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages.
Williams MD; Wright JR; March KL; Martin WJ
Am J Respir Cell Mol Biol; 1996 Mar; 14(3):232-8. PubMed ID: 8845173
[TBL] [Abstract][Full Text] [Related]
7. Surfactant protein-A reduces binding and phagocytosis of pneumocystis carinii by human alveolar macrophages in vitro.
Koziel H; Phelps DS; Fishman JA; Armstrong MY; Richards FF; Rose RM
Am J Respir Cell Mol Biol; 1998 Jun; 18(6):834-43. PubMed ID: 9618388
[TBL] [Abstract][Full Text] [Related]
8. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation.
Koziel H; Eichbaum Q; Kruskal BA; Pinkston P; Rogers RA; Armstrong MY; Richards FF; Rose RM; Ezekowitz RA
J Clin Invest; 1998 Oct; 102(7):1332-44. PubMed ID: 9769325
[TBL] [Abstract][Full Text] [Related]
9. Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species.
Atochina EN; Beck JM; Preston AM; Haczku A; Tomer Y; Scanlon ST; Fusaro T; Casey J; Hawgood S; Gow AJ; Beers MF
Infect Immun; 2004 Oct; 72(10):6002-11. PubMed ID: 15385504
[TBL] [Abstract][Full Text] [Related]
10. Identification of phagocytosed Pneumocystis carinii in human pulmonary alveolar macrophages.
Wehle K; Küpper T; Marzahn S; Pfitzer P
Cytopathology; 1993; 4(4):225-9. PubMed ID: 7691203
[TBL] [Abstract][Full Text] [Related]
11. Surfactant protein-D modulation of pulmonary macrophage phenotype is controlled by
Guo CJ; Atochina-Vasserman EN; Abramova E; Smith LC; Beers MF; Gow AJ
Am J Physiol Lung Cell Mol Physiol; 2019 Nov; 317(5):L539-L549. PubMed ID: 31411060
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.
Atochina EN; Beck JM; Scanlon ST; Preston AM; Beers MF
J Lab Clin Med; 2001 Jun; 137(6):429-39. PubMed ID: 11385364
[TBL] [Abstract][Full Text] [Related]
13. Delayed clearance of pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice.
Atochina EN; Gow AJ; Beck JM; Haczku A; Inch A; Kadire H; Tomer Y; Davis C; Preston AM; Poulain F; Hawgood S; Beers MF
J Infect Dis; 2004 Apr; 189(8):1528-39. PubMed ID: 15073692
[TBL] [Abstract][Full Text] [Related]
14. Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia.
Qu J; He L; Rong Z; Pan J; Chen X; Morrison DC; Li X
Chin Med J (Engl); 2001 Nov; 114(11):1143-6. PubMed ID: 11729507
[TBL] [Abstract][Full Text] [Related]
15. Exogenous heat-killed Escherichia coli improves alveolar macrophage activity and reduces Pneumocystis carinii lung burden in infant mice.
Empey KM; Hollifield M; Garvy BA
Infect Immun; 2007 Jul; 75(7):3382-93. PubMed ID: 17485459
[TBL] [Abstract][Full Text] [Related]
16. Steady-state effects of vitronectin and fibronectin on the binding, uptake, and degradation of Pneumocystis carinii in rat alveolar macrophages.
Hoyte JS; Standing JE; Limper AH
Inflammation; 1997 Jun; 21(3):335-45. PubMed ID: 9246575
[TBL] [Abstract][Full Text] [Related]
17. Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery.
Lasbury ME; Durant PJ; Bartlett MS; Smith JW; Lee CH
Clin Diagn Lab Immunol; 2003 Mar; 10(2):293-302. PubMed ID: 12626457
[TBL] [Abstract][Full Text] [Related]
18. 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A.
Zimmerman PE; Voelker DR; McCormack FX; Paulsrud JR; Martin WJ
J Clin Invest; 1992 Jan; 89(1):143-9. PubMed ID: 1530850
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection.
Linke MJ; Harris CE; Korfhagen TR; McCormack FX; Ashbaugh AD; Steele P; Whitsett JA; Walzer PD
J Infect Dis; 2001 Mar; 183(6):943-52. PubMed ID: 11237812
[TBL] [Abstract][Full Text] [Related]
20. Nitrated SP-A does not enhance adherence of Pneumocystis carinii to alveolar macrophages.
Zhu S; Kachel DL; Martin WJ; Matalon S
Am J Physiol; 1998 Dec; 275(6):L1031-9. PubMed ID: 9843839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
